SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff has pushed XRP toward and below the closely watched $1 level, putting that support zone at the center of the discussion; bearish traders warn of further losses if it gives way, while holders see the decline as a buying opportunity.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,719,016.041028 in circulation. The last known price of Algorand is 0.08513994 USD and is down -2.94 over the last 24 hours. It is currently trading on 586 active market(s) with $61,102,468.95 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention amid weak, volatile price action, with bearish traders warning of further downside while bulls frame the dips as accumulation and argue a recovery or altcoin rally is ahead. The debate also touches on Algorands quantum-resistant technology and tokenization potential, but no single confirmed development dominates.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and weakening technical structure are driving concern, with traders debating whether the oversold decline marks a buying opportunity or the start of a deeper downturn. Some cite rising yields, a stronger dollar, and ETF outflows as headwinds, while others expect a rebound.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Discussion centers on long-term HAE data for Intellias one-time CRISPR therapy lonvo-z and its FDA review path. Traders view the durability data as encouraging but are frustrated by the share decline, debating whether it reflects short-selling pressure or broader weakness in speculative biotech.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

A nationwide FAA ground stop after air-traffic-control communications failures disrupted departures and weighed on airline shares, including American Airlines. Traders debated whether the outage signaled a larger cyber or technology problem, but those theories remain unsubstantiated; the cause reported was a communications issue, with the ground stop later lifted.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

Tevas earnings beat and higher 2026 outlook, supported by growth in its innovative brands, are fueling bullish momentum and fresh-high chatter. Traders are also watching R&D pipeline updates and the pending FDA decision on at-home Igalmi, while some debate whether the sharp run-up can continue.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels Q3 report sparked a sharp selloff as an earnings miss and concerns about spending outweighed stronger product sales. Traders are divided: some see the early VEPPANU launch and upcoming R289 data as reasons for optimism, while others question whether growth will meet expectations.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Q3 results beat expectations and the company raised its outlook, prompting bullish reactions, but traders are debating whether growth elsewhere in the portfolio can offset biosimilar-driven declines in Prolia and Xgeva.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion centers on sharp swings in the Dow and broader equity market, with traders linking risk sentiment to Iran-related oil-supply concerns and rising Treasury yields/inflation. Views are split between crash warnings and expectations of a rebound as oil cools; there is no clear company-specific catalyst for this Dow-focused ETF.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp move in VKTX has fueled unconfirmed buyout and partnership speculation, especially around potential Big Pharma interest, alongside attention to VK2735 presentations at ObesityWeek. Traders are split between viewing the volume and options activity as signs of positioning or a squeeze and calling the rally rumor-driven; there is no confirmed deal or new Phase 3 efficacy readout, with pivotal data still ahead.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


gt66game

gt66 game